Cargando…
Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease
We introduce Synoviolin as a novel pathogenic factor in rheumatoid arthritis (RA). Experimental studies indicate that this endoplasmic reticulum (ER)-resident E3 ubiquitin ligase has important functions in the ER-associated degradation (ERAD) system, an essential system for ER homeostasis. Overexpre...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257448/ https://www.ncbi.nlm.nih.gov/pubmed/16207344 http://dx.doi.org/10.1186/ar1808 |
_version_ | 1782125808882548736 |
---|---|
author | Yamasaki, Satoshi Yagishita, Naoko Tsuchimochi, Kaneyuki Nishioka, Kusuki Nakajima, Toshihiro |
author_facet | Yamasaki, Satoshi Yagishita, Naoko Tsuchimochi, Kaneyuki Nishioka, Kusuki Nakajima, Toshihiro |
author_sort | Yamasaki, Satoshi |
collection | PubMed |
description | We introduce Synoviolin as a novel pathogenic factor in rheumatoid arthritis (RA). Experimental studies indicate that this endoplasmic reticulum (ER)-resident E3 ubiquitin ligase has important functions in the ER-associated degradation (ERAD) system, an essential system for ER homeostasis. Overexpression of Synoviolin in mice causes arthropathy with synovial hyperplasia, whereas heterozygous knockdown results in increased apoptosis of synovial cells and resistance to collagen-induced arthritis in mice. On the basis of these experimental data, we propose that excess elimination of unfolded proteins (that is, 'hyper-ERAD') by overexpression of Synoviolin triggers synovial cell overgrowth and hence a worsening of RA. Further analysis of the hyper-ERAD system may permit the complex pathomechanisms of RA to be uncovered. |
format | Text |
id | pubmed-1257448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-12574482005-10-19 Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease Yamasaki, Satoshi Yagishita, Naoko Tsuchimochi, Kaneyuki Nishioka, Kusuki Nakajima, Toshihiro Arthritis Res Ther Commentary We introduce Synoviolin as a novel pathogenic factor in rheumatoid arthritis (RA). Experimental studies indicate that this endoplasmic reticulum (ER)-resident E3 ubiquitin ligase has important functions in the ER-associated degradation (ERAD) system, an essential system for ER homeostasis. Overexpression of Synoviolin in mice causes arthropathy with synovial hyperplasia, whereas heterozygous knockdown results in increased apoptosis of synovial cells and resistance to collagen-induced arthritis in mice. On the basis of these experimental data, we propose that excess elimination of unfolded proteins (that is, 'hyper-ERAD') by overexpression of Synoviolin triggers synovial cell overgrowth and hence a worsening of RA. Further analysis of the hyper-ERAD system may permit the complex pathomechanisms of RA to be uncovered. BioMed Central 2005 2005-08-17 /pmc/articles/PMC1257448/ /pubmed/16207344 http://dx.doi.org/10.1186/ar1808 Text en Copyright © 2005 BioMed Central Ltd |
spellingShingle | Commentary Yamasaki, Satoshi Yagishita, Naoko Tsuchimochi, Kaneyuki Nishioka, Kusuki Nakajima, Toshihiro Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
title | Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
title_full | Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
title_fullStr | Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
title_full_unstemmed | Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
title_short | Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
title_sort | rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257448/ https://www.ncbi.nlm.nih.gov/pubmed/16207344 http://dx.doi.org/10.1186/ar1808 |
work_keys_str_mv | AT yamasakisatoshi rheumatoidarthritisasahyperendoplasmicreticulumassociateddegradationdisease AT yagishitanaoko rheumatoidarthritisasahyperendoplasmicreticulumassociateddegradationdisease AT tsuchimochikaneyuki rheumatoidarthritisasahyperendoplasmicreticulumassociateddegradationdisease AT nishiokakusuki rheumatoidarthritisasahyperendoplasmicreticulumassociateddegradationdisease AT nakajimatoshihiro rheumatoidarthritisasahyperendoplasmicreticulumassociateddegradationdisease |